Skip to main content

UCB's Global Corporate Website

Healthcare Professionals
Patients
Investor Relations
Careers

instagram
facebook
twitter
youtube
linkedin
rss

COVID-19 Twitter page

Main navigation

UCB - Inspired by patients. Driven by science. Chercher

Advantage Hers
Our Company
Disease Areas
- Disease areas
  - Epilepsy New
Our Science
Clinical Studies
Our Products
- Products
Newsroom
- Overview
- Press releases
  - Form
- Our stories
- Resources
- Contact
Patients
- Overview
- Life stories
Investors
Careers
- Applying to UCB
Go to global site

Search

Country Navigator

You are here

Home
UCB and COVID-19
COVID-19 Twitter page

COVID-19 Twitter posts

October 2020

COVID 19 tweet

September 2020

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

August 2020

COVID 19 tweet

July 2020

COVID 19 tweet

June 2020

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

May 2020

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

280_Tweet_COVID_22-5-2020

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

April 2020

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

March 2020

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

COVID 19 tweet

Choose a Country

Our Company

About us
Management
Health of the Planet
Partnering
Suppliers
Funding
Disclosure of payments
Responsible Procurement
Digital Business Transformation

Disease Areas

Disease Areas

Our Science

Pipeline
Drug discovery

UCB Worldwide

Select country Search

Our Products

Products

Newsroom

Overview
Press Releases
Our stories
Resources
Contact

Patients

Patients
Life stories

Investors

Overview
UCB equity story
UCB financials
UCB Governance
UCB shareholders
ESG overview
Download center
IR team

HCP

HCP Overview
dermatology

Clinical Studies

Overview
Current studies
Clinical studies index
General information
Data Transparency Policy

Advantage Hers

Advantage Hers English
Advantage Hers German
Advantage Hers French
Advantage Hers Spanish
Advantage Hers Italian
Advantage Hers Danish
Advantage Hers Dutch
Advantage Hers Polish
Advantage Hers Greek
Advantage Hers Finnish
Advantage Hers Norwegian
Advantage Hers Romanian
Advantage Hers Bulgarian
Advantage Hers Czech
Advantage Hers Slovak
Advantage Hers Australia
Advantage Hers Canada

FOLLOW US ON

Instagram
Facebook
Twitter
YouTube
LinkedIn
RSS

Careers
Contact us

© 2007 -2023 UCB S.A., Belgium. All rights reserved.

instagram
facebook
twitter
youtube
linkedin
rss

Footer menu

Legal Notice
Website Privacy Policy
Cookie policy
Cookie Preferences
Privacy Policy for Suppliers
Privacy Policy for Shareholders
Privacy Policy for Healthcare Professionals
Pharmacovigilance privacy policy
Contact Us / UCB CARES
UCB Worldwide
Sitemap

© 2007 - 2023 UCB S.A., Belgium. All rights reserved. Last updated on: April, 07, 2022